A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.

Stefic K, Tumiotto C, de Monte A, Wirden M, Rodallec A, Fofana D, Chaix ML, Bellecave P, Garnier E, Sourice J, Vellas C, Raymond S, Lambert-Niclot S, Alidjinou EK, Coulon P, Avettand-Fenoel V, Mchantaf G, Handala L, Alessandri-Gradt E, Moisan A, Lê M, Delaugerre C, Marcelin AG, Peytavin G, Calvez V, Descamps D, Charpentier C, Entry Inhibitors Observatory Study Group, Entry Inhibitors Observatory Study Group

Open source

DOI: 10.1093/ofid/ofag495
Published: 2026 Aug
Container: Open forum infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag495,
  title = {A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.},
  author = {Stefic K and Tumiotto C and de Monte A and Wirden M and Rodallec A and Fofana D and Chaix ML and Bellecave P and Garnier E and Sourice J and Vellas C and Raymond S and Lambert-Niclot S and Alidjinou EK and Coulon P and Avettand-Fenoel V and Mchantaf G and Handala L and Alessandri-Gradt E and Moisan A and Lê M and Delaugerre C and Marcelin AG and Peytavin G and Calvez V and Descamps D and Charpentier C and Entry Inhibitors Observatory Study Group and Entry Inhibitors Observatory Study Group},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag495},
  url = {https://doi.org/10.1093/ofid/ofag495}
}

RIS

TY  - JOUR
TI  - A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.
AU  - Stefic K
AU  - Tumiotto C
AU  - de Monte A
AU  - Wirden M
AU  - Rodallec A
AU  - Fofana D
AU  - Chaix ML
AU  - Bellecave P
AU  - Garnier E
AU  - Sourice J
AU  - Vellas C
AU  - Raymond S
AU  - Lambert-Niclot S
AU  - Alidjinou EK
AU  - Coulon P
AU  - Avettand-Fenoel V
AU  - Mchantaf G
AU  - Handala L
AU  - Alessandri-Gradt E
AU  - Moisan A
AU  - Lê M
AU  - Delaugerre C
AU  - Marcelin AG
AU  - Peytavin G
AU  - Calvez V
AU  - Descamps D
AU  - Charpentier C
AU  - Entry Inhibitors Observatory Study Group
AU  - Entry Inhibitors Observatory Study Group
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag495
UR  - https://doi.org/10.1093/ofid/ofag495
ER  -

APA

K, S., C, T., A, D. M., M, W., A, R., D, F., ML, C., P, B., E, G., J, S., C, V., S, R., S, L., EK, A., P, C., V, A., G, M., L, H., E, A., A, M., M, L., C, D., AG, M., G, P., V, C., D, D., C, C., Group, E. I. O. S., & Group, E. I. O. S. (2026). A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag495

Source records

pubmed · retrieved 2026-09-25T04:47:12.973Z